Clinical Trials Insight: 700019621

Trial Profile

Clinical Trials Insight: 700019621

Phase of Trial: Phase I

Latest Information Update: 04 Dec 2007

At a glance

  • Drugs Dronabinol (Primary)
  • Indications Neuropathic pain; Pain
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Cynapsus Therapeutics
  • Most Recent Events

    • 04 Dec 2007 Status changed to completed according to Cannasat Therapeutics' media release.
    • 27 Aug 2007 Status change from planning to initiated.
    • 11 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top